Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
Tóm tắt
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updates on cancer incidence and death rates and trends in these outcomes for the United States. This year's report includes the prevalence of comorbidity at the time of first cancer diagnosis among patients with lung, colorectal, breast, or prostate cancer and survival among cancer patients based on comorbidity level.
Data on cancer incidence were obtained from the NCI, the CDC, and the NAACCR; and data on mortality were obtained from the CDC. Long‐term (1975/1992‐2010) and short‐term (2001‐2010) trends in age‐adjusted incidence and death rates for all cancers combined and for the leading cancers among men and women were examined by joinpoint analysis. Through linkage with Medicare claims, the prevalence of comorbidity among cancer patients who were diagnosed between 1992 through 2005 residing in 11 Surveillance, Epidemiology, and End Results (SEER) areas were estimated and compared with the prevalence in a 5% random sample of cancer‐free Medicare beneficiaries. Among cancer patients, survival and the probabilities of dying of their cancer and of other causes by comorbidity level, age, and stage were calculated.
Death rates continued to decline for all cancers combined for men and women of all major racial and ethnic groups and for most major cancer sites; rates for both sexes combined decreased by 1.5% per year from 2001 through 2010. Overall incidence rates decreased in men and stabilized in women. The prevalence of comorbidity was similar among cancer‐free Medicare beneficiaries (31.8%), breast cancer patients (32.2%), and prostate cancer patients (30.5%); highest among lung cancer patients (52.9%); and intermediate among colorectal cancer patients (40.7%). Among all cancer patients and especially for patients diagnosed with local and regional disease, age and comorbidity level were important influences on the probability of dying of other causes and, consequently, on overall survival. For patients diagnosed with distant disease, the probability of dying of cancer was much higher than the probability of dying of other causes, and age and comorbidity had a smaller effect on overall survival.
Cancer death rates in the United States continue to decline. Estimates of survival that include the probability of dying of cancer and other causes stratified by comorbidity level, age, and stage can provide important information to facilitate treatment decisions.
Từ khóa
Tài liệu tham khảo
Wingo PA, 1998, Cancer incidence and mortality, 1973‐1995: a report card for the US, Cancer, 82, 1197, 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0
National Cancer Institute. SEER‐Medicare linked database. Available at:http://www.appliedresearch.cancer.gov/seermedicare/. Accessed November 6 2013.
Cho H, 2011, Estimating relative survival for cancer patients from the SEER Program using expected Rates Based on Ederer I versus Ederer II method. Technical Report 2011‐01
US Burden of Disease Collaborators, 2013, The state of US health, 1990‐2010: burden of diseases, injuries, and risk factors, JAMA, 310, 592
Smith AW, 2008, Cancer, comorbidities, and health‐related quality of life of older adults, Health Care Financ Rev, 29, 41
National Cancer Institute. Age distribution (%) of incidence cases by site 2006‐2010. Available at:http://seer.cancer.gov/csr/1975_2010/results_merged/topic_age_dist.pdf. Accessed November 6 2013.
World Health Organization, 2000, International Classification of Diseases for Oncology
Howlader N, 2013, SEER Cancer Statistics Review, 1975‐2010. [Based on the November 2012 SEER data submission, posted to the SEER web site, April 2013.]
National Cancer Institute. About the SEER Program. Available at:http://seer.cancer.gov/about/. Accessed November 6 2013.
National Cancer Institute.SEER Registry groupings for analyses. Available at:http://seer.cancer.gov/registries/terms.html. Accessed November 6 2013.
Murphy SL, 2013, Deaths: Final Data for 2010. National Vital Statistics Reports
National Center for Health Statistics.Manual of the International Statistical Classification of Diseases Injuries and Causes of Death Adapted for Use in the United States. 8th revised ed. Washington DC: National Center for Health Statistics Public Health Service US Department of Health Education and Welfare;1968.
World Health Organization, 1977, Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death [based on the recommendations of the Ninth Revision Conference, 1975]
World Health Organization, 1992, Manual of the International Statistical Classification of Diseases and Health Related Problems (ICD)
Surveillance Epidemiology and End Results (SEER) Program; National Cancer Institute. Population estimates used in NCI's SEER*Stat software. Available at:http://seer.cancer.gov/popdata/methods.html. Accessed May 8 2013.
National Vital Statistics System; Centers for Disease Control and Prevention. US census populations with bridged race categories. Available at:http://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed May 8 2013.
National Cancer Institute. US population data—1969‐2011. Available at:http://seer.cancer.gov/popdata/. Accessed November 6 2013.
EngelsEA PfeifferRM RickerW WheelerW ParsonsR WarrenJL.Use of Surveillance Epidemiology and End Results‐Medicare data to conduct case‐control studies of cancer among the US elderly.Am J Epidemiol.2011;174:860‐870.
Surveillance Epidemiology and End Results Program; National Cancer Institute. SEER*Stat software version 8.0.4 [software program]. Available at:www.seer.cancer.gov/seerstat. Accessed November 6 2013.
Cancer Control and Population Sciences; National Cancer Institute. Joinpoint regression program [software program]. Available at:http://surveillance.cancer.gov/joinpoint/. Accessed November 6 2013.
Surveillance Epidemiology and End Results (SEER) Program; National Cancer Institute. SEER cause‐specific death classification. Available at:http://seer.cancer.gov/causespecific/. Accessed August 1 2013.
Surveillance Epidemiology and End Results (SEER) Program; National Cancer Institute. SEER coding and staging manuals. Available at:http://seer.cancer.gov/tools/codingmanuals/. Accessed November 6 2013.
Surveillance Epidemiology and End Results (SEER) Program; National Cancer Institute. SEER summary staging manual—2000. Available at:http://seer.cancer.gov/tools/ssm/. Accessed November 6 2013.
Colditz G, 2006, Cancer Epidemiology and Prevention, 959
Collins EN, 2011, The Collaborative Stage Version 2 Data Validation Project, 2010, J Registry Manag, 38, 39
National Cancer Institute. Cancer statistics review: technical notes. Available at:http://seer.cancer.gov/csr/1975_2010/results_figure/sect_01_intro2_24pgs.pdf. Accessed November 6 2013.
US Department of Health and Human Services, 2010, Multiple Chronic Conditions—A Strategic Framework: Optimum Health and Quality of Life for Individuals With Multiple Chronic Conditions
Wagner EH, 1998, Chronic disease management: what will it take to improve care for chronic illness?, Eff Clin Pract, 1, 2
Committee on Quality of Health Care in America; Institute of Medicine, 2001, Crossing the Quality Chasm: A New Health System for the 21st Century
Anderson G, 2010, Chronic Care: Making the Case for Ongoing Care
Committee on Living Well With Chronic Disease: Public Health Action to Reduce Disability and Improve Functioning and Quality of Life; Institute of Medicine, 2012, Living Well With Chronic Illness: A Call for Public Health Action
National Cancer Institute. Patterns of care/quality of care studies. Available at:http://appliedresearch.cancer.gov/surveys/poc/. Accessed November 6 2013.
Centers for Disease Control and Prevention. Comparative Effectiveness Research Data Collection Enhancement Project. Available at:http://www.cdc.gov/cancer/npcr/cer_data_collection.htm. Accessed November 6 2013.
CohnD.State population estimates and census 2010 counts: did they match? Washington DC: Pew Research Center; 2011. Available at:http://www.pewsocialtrends.org/2011/01/12/state‐population‐estimates‐and‐census‐2010‐counts‐did‐they‐match/. Accessed November 6 2013.
Humes KR, 2011, Overview of Race and Hispanic Origin: 2010. 2010 Census Briefs
Ennis SR, 2011, The Hispanic Population: 2010. 2010 Census Briefs
Norris T, 2012, The American Indian and Alaska Native Population: 2010. 2010 Census Briefs
Hoeffel EM, 2012, The Asian Population: 2010. 2010 Census Briefs
Hixson L, 2012, The Native Hawaiian and Other Pacific Islander Population: 2010. 2010 Census Briefs
Werner CA, 2011, The Older Population: 2010. 2010 Census Briefs
Arias E, 2008, The validity of race and Hispanic origin reporting on death certificates in the United States, Vital Health Stat 2, 148, 1
National Cancer Institute.Estimated US cancer prevalence counts: method. Available at:http://cancercontrol.cancer.gov/ocs/prevalence/prevalence.html. Accessed November 6 2013.
National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health, 2013, The State of Aging and Health in America 2013
US Department of Health and Human Services, 2011, National Prevention Strategy
US Department of Health and Human Services. Behavioral interventions to address multiple chronic health conditions in primary care. Available at:http://grants.nih.gov/grants/guide/pa‐files/PA‐12‐024.html. Accessed November 6 2013.
US Department of Health and Human Services. Examination of Survivorship Care Planning Efficacy and Impact (R01). Available at:http://grants.nih.gov/grants/guide/pa‐files/PA‐12‐024.html. Accessed November 6 2013.